ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer

NCT00662597 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1285

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: ASA404
DRUG: Placebo
DRUG: carboplatin
DRUG: Paclitaxel

Sponsor

Novartis Pharmaceuticals